Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Serial Diaphragm Ultrasound Evaluation During Inspiratory Muscle Training in Prolonged Mechanical Ventilation

16 de julio de 2026 actualizado por: MENG-JER HSIEH, Chang Gung Memorial Hospital

Diaphragm Ultrasound Evaluation of the Effects of High Intensity or Low Intensity Inspiratory Muscle Training in Patients With Prolonged Mechanical Ventilation

Diaphragm dysfunction contributes to prolonged mechanical ventilation (PMV) and difficult weaning. Inspiratory muscle training (IMT) may improve respiratory muscle performance, while serial diaphragm ultrasound offers a bedside method for monitoring diaphragmatic recovery. This study used diaphragm ultrasound to evaluate the effects of high- versus low-intensity IMT in patients with PMV and diaphragm dysfunction.

In this prospective study, patients received high- or low-intensity IMT for up to 2 weeks or until ventilator liberation. Respiratory mechanics, including respiratory rate, tidal volume, minute ventilation, rapid shallow breathing index, and maximal inspiratory pressure, were assessed twice weekly. Diaphragm excursion and thickening fraction were also measured serially after IMT initiation. Changes in respiratory physiological parameters and diaphragm ultrasound measurements were compared between the two IMT groups, and differences in ventilator liberation outcomes were evaluated.

Descripción general del estudio

Descripción detallada

Prolonged mechanical ventilation (PMV) is associated with substantial morbidity, mortality, and healthcare resource utilization. In Taiwan, approximately 170,000 patients receive mechanical ventilation annually, of whom an estimated 13%-16% remain ventilator-dependent for more than 21 days and 3.7%-5.6% require ventilatory support for more than 63 days. Diaphragm dysfunction is an important physiological contributor to difficult ventilator liberation. Prolonged mechanical unloading, systemic inflammation, critical illness, and disuse may result in diaphragmatic atrophy, structural injury, and impaired contractility.

Inspiratory muscle training (IMT) is used during ventilator rehabilitation to improve inspiratory muscle strength and endurance. IMT may be delivered using resistive-loading or threshold-loading devices. Threshold-loading devices provide a relatively constant, flow-independent inspiratory resistance and permit training intensity to be prescribed according to maximal inspiratory pressure (Pimax). Similar to peripheral skeletal muscle training, respiratory muscle adaptation is influenced by the magnitude and progression of the applied workload. However, the appropriate training intensity for patients with PMV and diaphragm dysfunction remains uncertain. Higher-intensity training may provide a stronger physiological stimulus but may be less well tolerated, whereas lower-intensity training may be easier to perform but may produce a smaller training response.

The effects of IMT have traditionally been evaluated using global respiratory measurements such as Pimax, tidal volume, respiratory rate, minute ventilation, and the rapid shallow breathing index. Although these measurements provide clinically relevant information, most are effort-dependent and do not directly assess diaphragm-specific mechanical recovery. Point-of-care diaphragm ultrasound provides a noninvasive bedside method for serial evaluation of diaphragmatic function. Diaphragm excursion reflects craniocaudal diaphragmatic displacement during inspiration, while diaphragm thickening fraction reflects inspiratory muscle contraction within the zone of apposition.

This prospective, single-center, randomized controlled trial compared high-intensity and low-intensity inspiratory muscle training (IMT) in adults with prolonged mechanical ventilation and inspiratory muscle weakness who had been transferred from an intensive care unit to a specialized respiratory care center. Eligible participants were randomly assigned to receive an individualized IMT workload based on baseline maximal inspiratory pressure (Pimax). The high-intensity group trained at 50% of baseline Pimax, and the low-intensity group trained at 20% of baseline Pimax.

IMT was administered using a Dofin® adjustable-resistance threshold inspiratory muscle trainer (GaleMed Corporation, Taiwan). During each training session, the device was connected directly to the endotracheal or tracheostomy tube by a respiratory therapist after temporary disconnection from the mechanical ventilator. Each cycle included 6-10 inspiratory efforts, and five cycles were performed daily. Rest periods of 1-3 minutes were provided between cycles to reduce acute respiratory muscle fatigue. Pimax was reassessed twice weekly, and the training resistance was adjusted according to the updated measurement.

Participants were continuously observed during IMT for signs of respiratory distress or hemodynamic instability. Training was discontinued and mechanical ventilation was resumed when clinically significant oxygen desaturation, tachycardia, arrhythmia, diaphoresis, pallor, cyanosis, altered mental status, severe dyspnea, or other evidence of intolerance occurred. When a participant could not tolerate the prescribed high-intensity workload, resistance was reduced in 10% increments. A session was terminated when intolerance persisted after a reduction of more than 20% from the prescribed workload. Training continued for up to 2 weeks or until successful liberation from mechanical ventilation.

Baseline demographic and clinical characteristics were prospectively recorded. Respiratory mechanics, including respiratory rate, tidal volume, minute ventilation, rapid shallow breathing index, and Pimax, were assessed twice weekly during the intervention period. Mechanical ventilation duration and ventilator days after IMT initiation were also recorded.

Point-of-care diaphragm ultrasound was performed at baseline and on days 4, 7, and 10 after IMT initiation. During ultrasound assessment, ventilatory support was changed to continuous positive airway pressure mode to standardize the measurement condition. Right diaphragmatic excursion was measured using M-mode ultrasonography with a convex-array transducer positioned near the intersection of the right costal margin and midclavicular line. Diaphragm thickness was measured using a high-frequency linear-array transducer placed over the right zone of apposition near the anterior axillary line. Thickening fraction was calculated from the difference between inspiratory and expiratory diaphragm thickness relative to expiratory thickness.

Serial changes in respiratory mechanics and diaphragm ultrasound measurements were compared between the high-intensity and low-intensity inspiratory muscle training groups using statistical methods appropriate for repeated measurements. Ventilator liberation was evaluated using time-to-event methods. Kaplan-Meier analysis was used to compare the cumulative probability of successful ventilator liberation, with participants who did not achieve liberation censored at 28 days. Group differences were assessed using the log-rank test, and Cox proportional hazards regression was used to evaluate the association between inspiratory muscle training intensity and time to successful ventilator liberation.

The study was approved by the Institutional Review Board of Chang Gung Medical Foundation, Taiwan. Written informed consent was obtained from each participant's legally authorized representative before enrollment. Study procedures were conducted in accordance with the Declaration of Helsinki.

Tipo de estudio

Intervencionista

Inscripción (Actual)

36

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

      • Taoyuan, Taiwán
        • Linkou Gung Memorial Hospital

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

No

Descripción

Inclusion Criteria:

  1. Willing and able to provide written informed consent.
  2. Adults aged >20 years.
  3. Patients requiring mechanical ventilation for >21 days and admitted to the Respiratory Care Center (RCC).
  4. Hemodynamically stable and not receiving vasopressor therapy.
  5. Clinically stable and considered by the attending physician to be ready to begin weaning from mechanical ventilation. Ventilator settings must meet all of the following criteria:

(1) Fraction of inspired oxygen (FiO₂) < 0.60. (2) Positive end-expiratory pressure (PEEP) ≤10 cmH₂O. (3) Able to trigger spontaneous breaths on the ventilator. (4) Respiratory rate <25 breaths/min. (5) Respiratory muscle weakness confirmed by maximal inspiratory pressure (MIP), defined as MIP <30 cmH₂O.

Exclusion Criteria:

  1. Hemodynamic instability, including cardiac arrhythmia, decompensated heart failure, or acute coronary syndrome.
  2. Active hemoptysis.
  3. Presence of a chest tube.
  4. Use of home mechanical ventilation.
  5. Uncontrolled pain or dyspnea.
  6. Patients determined to be ventilator-dependent and requiring long-term mechanical ventilation.
  7. Patients or their legally authorized representatives who are unwilling or unable to provide written informed consent.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: high intensity IMT
high IMT training intensity
high intensity IMT: high intensity training
Comparador activo: low intensity IMT
low IMT training intensity
low intensity IMT: low intensity training

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Periodo de tiempo
Changes in diaphragm excursion measured by diaphragm ultrasound
Periodo de tiempo: From enrollment to the end of study at 2 weeks.
From enrollment to the end of study at 2 weeks.
Changes in thickening fraction measured by diaphragm ultrasound
Periodo de tiempo: From enrollment to the end of study at 2 weeks.
From enrollment to the end of study at 2 weeks.

Medidas de resultado secundarias

Medida de resultado
Periodo de tiempo
Successful ventilator liberation
Periodo de tiempo: From enrollment to the end of study at 2 weeks.
From enrollment to the end of study at 2 weeks.
Change in maximal inspiratory pressure (PImax)
Periodo de tiempo: From enrollment to the end of study at 2 weeks.
From enrollment to the end of study at 2 weeks.
Change in respiratory rate (RR)
Periodo de tiempo: From enrollment to the end of study at 2 weeks.
From enrollment to the end of study at 2 weeks.
Change in tidal volume (VT)
Periodo de tiempo: From enrollment to the end of study at 2 weeks.
From enrollment to the end of study at 2 weeks.
Change in minute ventilation (MV)
Periodo de tiempo: From enrollment to the end of study at 2 weeks.
From enrollment to the end of study at 2 weeks.
Change in rapid shallow breathing index (RSBI)
Periodo de tiempo: From enrollment to the end of study at 2 weeks.
From enrollment to the end of study at 2 weeks.

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

9 de marzo de 2023

Finalización primaria (Actual)

27 de mayo de 2025

Finalización del estudio (Actual)

30 de junio de 2025

Fechas de registro del estudio

Enviado por primera vez

7 de julio de 2026

Primero enviado que cumplió con los criterios de control de calidad

16 de julio de 2026

Publicado por primera vez (Actual)

17 de julio de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

17 de julio de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

16 de julio de 2026

Última verificación

1 de julio de 2026

Más información

Términos relacionados con este estudio

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir